The Valley Desk

NCT04544293 · Interventional trial

Clinical Trial of Inhaled Molgramostim Nebulizer Solution in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)

Overall registry status Active not recruiting

Phase 3

Conditions Autoimmune Pulmonary Alveolar Proteinosis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov